[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Achilli et al., 2020 - Google Patents

TETRALEC, artificial tetrameric lectins: a tool to screen ligand and pathogen interactions

Achilli et al., 2020

View HTML
Document ID
15173187791697602712
Author
Achilli S
Monteiro J
Serna S
Mayer-Lambertz S
Thépaut M
Le Roy A
Ebel C
Reichardt N
Lepenies B
Fieschi F
Vivès C
Publication year
Publication venue
International journal of molecular sciences

External Links

Snippet

C-type lectin receptor (CLR)/carbohydrate recognition occurs through low affinity interactions. Nature compensates that weakness by multivalent display of the lectin carbohydrate recognition domain (CRD) at the cell surface. Mimicking these low affinity …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/5308—Immunoassay; Biospecific binding assay for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature

Similar Documents

Publication Publication Date Title
Geissner et al. Microbe-focused glycan array screening platform
Itakura et al. Sugar-binding profiles of chitin-binding lectins from the hevein family: A comprehensive study
Achilli et al. TETRALEC, artificial tetrameric lectins: a tool to screen ligand and pathogen interactions
Hu et al. Lectin engineering, a molecular evolutionary approach to expanding the lectin utilities
Ristow et al. RTX toxins ambush immunity’s first cellular responders
Díez et al. NAPPA as a real new method for protein microarray generation
Hirano et al. Biosynthesis and biological significances of LacdiNAc group on N-and O-glycans in human cancer cells
Kim et al. Novel antibodies targeting MUC1-C showed anti-metastasis and growth-inhibitory effects on human breast cancer cells
Cho et al. Systemic lectin-glycan interaction of pathogenic enteric bacteria in the gastrointestinal tract
Amon et al. Directed evolution of therapeutic antibodies targeting glycosylation in cancer
Yahiro et al. New insights into VacA intoxication mediated through its cell surface receptors
Malinovská et al. Synthesis of β-D-galactopyranoside-presenting glycoclusters, investigation of their interactions with Pseudomonas aeruginosa lectin A (PA-IL) and evaluation of their anti-adhesion potential
Krylov et al. Reinvestigation of carbohydrate specificity of EBCA-1 monoclonal antibody used for the detection of Candida mannan
Burkin et al. Specific and generic immunorecognition of glycopeptide antibiotics promoted by unique and multiple orientations of hapten
Lande et al. Generation of monoclonal antibodies specific for native LL37 and citrullinated LL37 that discriminate the two LL37 forms in the skin and circulation of cutaneous/systemic lupus erythematosus and rheumatoid arthritis patients
Siao et al. Tamm-Horsfall glycoprotein enhances PMN phagocytosis by binding to cell surface-expressed lactoferrin and cathepsin G that activates MAP kinase pathway
Soga et al. Mammalian cell surface display as a novel method for developing engineered lectins with novel characteristics
Slámová et al. Oligosaccharide ligands of galectin-4 and its subunits: multivalency scores highly
Shao et al. Hapten synthesis and monoclonal antibody preparation for simultaneous detection of albendazole and its metabolites in animal-origin food
Roucka et al. Application of lectin array technology for biobetter characterization: Its correlation with FcγRIII binding and ADCC
Vitry et al. Regulation of the expression, oligomerisation and signaling of the inhibitory receptor CLEC12A by cysteine residues in the stalk region
Oda et al. Fabrication of fragment antibody–enzyme complex as a sensing element for immunosensing
Dobrochaeva et al. Human natural antibodies recognizing glycan Galβ1-3GlcNAc (LeC)
Thongkum et al. Latticed gold nanoparticle conjugation via monomeric streptavidin in lateral flow assay for detection of autoantibody to interferon-gamma
Song et al. Effects of highly pathogenic porcine reproductive and respiratory syndrome virus infection on the surface glycoprofiling of porcine pulmonary microvascular endothelial cells